Company Name:  PharmAthene Inc  Ticker Symbol:  PIP  CIK Number:  0001326190  WWW Address:  http://www.pharmathene.com 
CEO:  John Gill  No. of Employees:  13 
Common Issue Type:  CS  Business Description:  PharmAthene, Inc., is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

  Industry Information:  DRUGS  Biotechnology [more like this] 
 Price  Day Change  Bid  Ask  Open  High  Low  Volume  0.65  0.0       0.73  0.63   
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
44.7  68.8  0.00  2.97  0.00  0.2  0.0  4.00  0.47 
 KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  0.65  $  PE Ratio  LTM  0.2  
Market Capitalisation  44.7  mil 
Latest Shares Outstanding  68.8  mil 
Earnings pS (EPS)  2.97  $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee  402,323  $ 
Effective Tax Rate  0.1  % 
Float  65.1  mil 
Float as % of Shares Outstanding  0.9  % 
Foreign Sales   mil 
Domestic Sales  5  mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  2.20  % 
Research & Devlopment (R&D) as % of Revenue  0.90  % 
Gross Profit Margin  0.0  % 
EBITDA Margin  212.6  % 
PreTax Profit Margin  0.0  % 
Assets Turnover  4.3  % 
Return on Assets (ROA)  158.5  % 
Return on Equity (ROE)  1073.7  % 
Return on Capital Invested (ROCI)  1073.7  % 
Current Ratio  1.1  
Leverage Ratio (Assets/Equity)  11.5  
Interest Cover   
Total Debt/Equity (Gearing Ratio)   
LT Debt/Total Capital  0.0  % 
Working Capital pS  0.25  $ 
Cash pS  0.00  $ 
BookValue pS  0.28  $ 
Tangible BookValue pS  0.25  $ 
Cash Flow pS  3.07  $ 
Free Cash Flow pS  3.07  $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  2.57  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow  0.2  
Price/Free Cash Flow  0.2  
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  0.0 
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
    PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        5.8  6  672,181  
4 Weeks  0.82  0.63  0.77  15.5  17  580,523  9,868,895 
13 Weeks  1.47  0.47  1.01  35.6  40  4,459,730  272,043,571 
26 Weeks  4.00  0.47  2.80  76.8  89  2,805,421  342,261,382 
52 Weeks  4.00  0.47  2.33  72.1  87  1,481,329  368,851,115 
YTD  3.50  0.47    80.3  86  3,639,270  305,698,710 
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 0.70  0.71  0.78  2.12  2.28  0.00  0.00 
  GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue  0.26  0.0  0.34 
Income   0.8  
Dividend   0.0  
Capital Spending   NA  
R&D  3.70  NA  9.74 
Normalized Inc.  0.00  NA  0.00 
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %  5.3  5.3  3.7 
Earnings %  0.0  0.0  0.0 
EPS %  0.0  0.0  0.0 
EPS $  0.02  0.02  0.02 
  SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  7.76 
Current Ratio  1.1 
Quick Ratio (Acid Test)  1.1 
Liquidity Ratio (Cash)  1.83 
Receivables Turnover  12.9 
Average Collection Period  28 
Working Capital/Equity  89.6 
Working Capital pS  0.25 
CashFlow pS  3.07 
Free CashFlow pS  3.07 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  1.28 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  0.0 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  2.3 
LT Debt/Total Liabilities  0.0 
Interest Cover  0.0 
Interest/Capital Invested  0.00 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  0.23 
Current P/E Ratio  LTM  0.20 
Enterprise Value (EV)/EBITDA  10.67 
Enterprise Value (EV)/Free Cash Flow  1.58 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  2.57 
Price/Cash Flow Ratio  0.2 
Price/Free Cash Flow Ratio  LTM  0.2 
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  0.0 
P/E Ratio (26 weeks ago)  LTM  0.0 
P/E Ratio (52 weeks ago)  LTM  0.0 
5Y High P/E Ratio  1.2 
5Y Low P/E Ratio  0.2 
5Y Average P/E Ratio  0.0 
Current P/E Ratio as % of 5Y Average P/E  63 
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  0.00 
Current Liabilities pS  3.15 
Tangible Book Value pS  LTM  0.25 
Book Value pS  LTM  0.28 
Capital Invested pS  0.28 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  3.07 
Free Cash Flow pS  LTM  3.07 
Earnings pS (EPS)  2.97 
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  3,852.20 
Free Cash Flow Margin 5YEAR AVG  737.48 
Net Profit Margin  37.1 
Net Profit Margin  5YEAR AVRG.  7.0 
Equity Productivity  0.27 
Return on Equity (ROE)  10.7 
Return on Equity (ROE)  5YEAR AVRG.  1.6 
Capital Invested Productivity  0.27 
Return on Capital Invested (ROCI)  1.7 
Return on Capital Invested (ROCI)  5YEAR AVRG.  1.7 
Assets Productivity  0.00 
Return on Assets (ROA)  1.6 
Return on Assets (ROA)  5YEAR AVRG.  0.0 
Gross Profit Margin  0.0 
Gross Profit Margin  5YEAR AVRG.  
EBITDA Margin  LTM  212.6 
EBIT Margin  LTM  215.4 
PreTax Profit Margin  7.4 
PreTax Profit Margin  5YEAR AVRG.  7.4 
Effective Tax Rate  28.0 
Effective Tax Rate  5YEAR AVRG.  6.4 
EFFICIENCY RATIOS 
Cash Conversion Cycle  35,185 
Revenue per Employee  402,323 
Net Income per Employee  14,911,859 
Average Collection Period  35,185 
Receivables Turnover  12.9 
Day's Inventory Turnover Ratio  
Inventory Turnover  0.0 
Inventory/Sales  0.0 
Accounts Payble/Sales  17.71 
Assets/Revenue  0.00 
Net Working Capital Turnover  0.30 
Fixed Assets Turnover  2.12 
Total Assets Turnover  0.0 
Revenue per $ Cash  0.03 
Revenue per $ Plant  43.24 
Revenue per $ Common Equity  0.27 
Revenue per $ Capital Invested  0.27 
Selling, General & Adm/tive (SG&A) as % of Revenue  220.2 
SG&A Expense as % of Revenue  5YEAR AVRG.  0.0 
Research & Devlopment (R&D) as % of Revenue  92.5 
R&D Expense as % of Revenue  5YEAR AVRG.  92.5 

      